Terms: = Lymphoma AND FOXP1, MGC12942, 27086, ENSG00000114861, hFKH1B, MGC99551, FLJ23741, QRF1, 12CC4, HSPC215, MGC88572 AND Treatment
23 results:
1. Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.
Tan KW; Zhu YY; Qiu QC; Wang M; Shen HJ; Huang SM; Cao HY; Wan CL; Li YY; Dai HP; Xue SL
Ann Hematol; 2023 Sep; 102(9):2397-2402. PubMed ID: 37103615
[TBL] [Abstract] [Full Text] [Related]
2. Indurated Plaques on the Legs: Think lymphoma.
Watts-Santos A; Cuellar-Barboza A; Ramos-Cavazos CJ; Villarreal-Martinez A; Ocampo-Candiani J; Herz-Ruelas ME
Acta Dermatovenerol Croat; 2021 Jul; 29(2):114-115. PubMed ID: 34477080
[TBL] [Abstract] [Full Text] [Related]
3. BCR-ABL1-like B-Lymphoblastic Leukemia/lymphoma with foxp1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use.
Yenamandra AK; Kaviany S; Borinstein SC; Friedman DL; Kovach AE
Lab Med; 2019 Oct; 50(4):401-405. PubMed ID: 30938769
[TBL] [Abstract] [Full Text] [Related]
4. Primary Cutaneous Diffuse Large B-Cell lymphoma, Leg Type, With Spontaneous Regression After Biopsy.
Marrero-Alemán G; Montenegro-Dámaso T; Peñate Y
Am J Dermatopathol; 2017 Oct; 39(10):785-787. PubMed ID: 28926365
[TBL] [Abstract] [Full Text] [Related]
5. The small foxp1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length foxp1 exert similar oncogenic and transcriptional activity in human B cells.
van Keimpema M; Grüneberg LJ; Schilder-Tol EJ; Oud ME; Beuling EA; Hensbergen PJ; de Jong J; Pals ST; Spaargaren M
Haematologica; 2017 Mar; 102(3):573-583. PubMed ID: 27909217
[TBL] [Abstract] [Full Text] [Related]
6. High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.
Marques SC; Ranjbar B; Laursen MB; Falgreen S; Bilgrau AE; Bødker JS; Jørgensen LK; Primo MN; Schmitz A; Ettrup MS; Johnsen HE; Bøgsted M; Mikkelsen JG; Dybkær K
Exp Hematol; 2016 Apr; 44(4):238-46.e2. PubMed ID: 26854484
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling.
Menter T; Dickenmann M; Juskevicius D; Steiger J; Dirnhofer S; Tzankov A
Hematol Oncol; 2017 Jun; 35(2):187-197. PubMed ID: 26799990
[TBL] [Abstract] [Full Text] [Related]
8. Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of "germinotropic" lymphoproliferative disorder.
Lorenzi L; Lonardi S; Essatari MH; Pellegrini V; Fisogni S; Gazzola A; Agostinelli C; Vermi W; Rossi G; Massarelli G; Pileri SA; Facchetti F
Virchows Arch; 2016 Apr; 468(4):441-50. PubMed ID: 26762526
[TBL] [Abstract] [Full Text] [Related]
9. Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium.
Deng L; Xu-Monette ZY; Loghavi S; Manyam GC; Xia Y; Visco C; Huh J; Zhang L; Zhai Q; Wang Y; Qiu L; Dybkær K; Chiu A; Perry AM; Zhang S; Tzankov A; Rao H; Abramson J; Sohani AR; Xu M; Hsi ED; Zhu J; Ponzoni M; Wang S; Li L; Zhang M; Ferreri AJ; Parsons BM; Li Y; Piris MA; Medeiros LJ; Young KH
Leukemia; 2016 Feb; 30(2):361-72. PubMed ID: 26308769
[TBL] [Abstract] [Full Text] [Related]
10. Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.
Vanacker L; Smeets D; Hoorens A; Teugels E; Algaba R; Dehou MF; De Becker A; Lambrechts D; De Greve J
Anticancer Res; 2014 Oct; 34(10):5517-21. PubMed ID: 25275049
[TBL] [Abstract] [Full Text] [Related]
11. [The clinical characteristics and prognostic analysis of 147 cases of diffuse large B-cell lymphoma].
Zhao Q; Fu WJ; Zhang CY; Du J; Xi H; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):737-40. PubMed ID: 24103868
[TBL] [Abstract] [Full Text] [Related]
12. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
[TBL] [Abstract] [Full Text] [Related]
13. Indolent cutaneous B-cell lymphoma: diagnosis and treatment 2012.
Santucci M; Grandi V; Maio V; Delfino C; Alterini R; Pimpinelli N
G Ital Dermatol Venereol; 2012 Dec; 147(6):581-8. PubMed ID: 23149704
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathologic study and outcome analysis of thyroid lymphomas: experience from a tertiary cancer center.
Katna R; Shet T; Sengar M; Menon H; Laskar S; Prabhash K; D'Cruz A; Nair R
Head Neck; 2013 Feb; 35(2):165-71. PubMed ID: 22368156
[TBL] [Abstract] [Full Text] [Related]
15. The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.
Thieblemont C; Briere J; Mounier N; Voelker HU; Cuccuini W; Hirchaud E; Rosenwald A; Jack A; Sundstrom C; Cogliatti S; Trougouboff P; Boudova L; Ysebaert L; Soulier J; Chevalier C; Bron D; Schmitz N; Gaulard P; Houlgatte R; Gisselbrecht C
J Clin Oncol; 2011 Nov; 29(31):4079-87. PubMed ID: 21947824
[TBL] [Abstract] [Full Text] [Related]
16. Expression of PIK3CA and foxp1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type.
Zhai L; Zhao Y; Ye S; Huang H; Tian Y; Wu Q; Lin H; Lin T
Tumour Biol; 2011 Oct; 32(5):913-20. PubMed ID: 21660567
[TBL] [Abstract] [Full Text] [Related]
17. Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of foxp1.
Craig VJ; Cogliatti SB; Imig J; Renner C; Neuenschwander S; Rehrauer H; Schlapbach R; Dirnhofer S; Tzankov A; Müller A
Blood; 2011 Jun; 117(23):6227-36. PubMed ID: 21460242
[TBL] [Abstract] [Full Text] [Related]
18. [Gastric MALT lymphoma: recent topics regarding treatment and genetic aberrations].
Nakamura S; Matsumoto T; Iida M
Nihon Rinsho; 2009 Dec; 67(12):2327-31. PubMed ID: 19999120
[TBL] [Abstract] [Full Text] [Related]
19. Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034.
Chadburn A; Chiu A; Lee JY; Chen X; Hyjek E; Banham AH; Noy A; Kaplan LD; Sparano JA; Bhatia K; Cesarman E
J Clin Oncol; 2009 Oct; 27(30):5039-48. PubMed ID: 19752343
[TBL] [Abstract] [Full Text] [Related]
20. The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.
Jais JP; Haioun C; Molina TJ; Rickman DS; de Reynies A; Berger F; Gisselbrecht C; Brière J; Reyes F; Gaulard P; Feugier P; Labouyrie E; Tilly H; Bastard C; Coiffier B; Salles G; Leroy K;
Leukemia; 2008 Oct; 22(10):1917-24. PubMed ID: 18615101
[TBL] [Abstract] [Full Text] [Related]
[Next]